TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
7 hedge funds and large institutions have $1M invested in TIANYIN PHARMACEUTICAL in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
40% less capital invested
Capital invested by funds: $1.69M → $1M (-$681K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$21.7K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$3.6K |
Top Sellers
| 1 |
PAM
Pope Asset Management
Memphis,
Tennessee
|
-$508K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.26K |
| 3 |
SIM
Spark Investment Management
New York
|
-$1.77K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
1
Pope Asset Management
Memphis,
Tennessee
| $504K | -$508K | -803,269 | -50% |
|
|
2
Renaissance Technologies
New York
| $457K | +$21.7K | +34,300 | +5% |
|
|
RIM
3
Regent Investment Management
Louisville,
Kentucky
| $16K | – | – | – |
|
|
SIM
4
Spark Investment Management
New York
| $12K | -$1.77K | -2,800 | -13% |
|
|
5
Citadel Advisors
Miami,
Florida
| $9K | -$2.26K | -3,577 | -19% |
|
|
U
6
UBS
Zurich,
Switzerland
| $4K | +$3.6K | +5,690 | New |
|
|
BWFA
7
Baltimore-Washington Financial Advisors
Columbia,
Maryland
| $3K | – | – | – |
|
TPI Hedge Fund Activity: Q3 2014 in Review
7 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q3 2014, worth a combined $1M — down 40% from $1.69M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new TPI positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $21.7K. The largest seller was Pope Asset Management, cutting an estimated $508K.
- 7 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q3 2014, up from 6 in Q2 2014.
- Funds reported $1M of TIANYIN PHARMACEUTICAL stock for Q3 2014, down 40% quarter-over-quarter.
- 1 fund opened new TIANYIN PHARMACEUTICAL positions in Q3 2014 and 0 closed out, a net change of +1 holder.
- The largest TIANYIN PHARMACEUTICAL buyer in Q3 2014 was Renaissance Technologies, an estimated $21.7K added.
- The largest TIANYIN PHARMACEUTICAL seller in Q3 2014 was Pope Asset Management, an estimated $508K sold.
Based on aggregated 13F filings for Q3 2014.